Oxford BioDynamics
-
Oxford BioDynamics appoints non-executive chairman
The biotechnology company developing personalised medicine tests based on 3D genomic biomarkers, has announced that Matthew Wakefield as its Non-Executive Chairman.
The biotechnology company developing personalised medicine tests based on 3D genomic biomarkers, has announced that Matthew Wakefield as its Non-Executive Chairman.
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
